COVID-19 Diagnostics and Treatments

The Innovative Medicines Initiative has provisionally selected 8 projects for funding from its fast-track Call for proposals on coronavirus diagnostics and treatments. In addition, it has boosted the IMI funding pot from EUR 45 million to EUR 72 million. On top of this, EFPIA companies, IMI Associated Partners and other organisations will contribute over EUR…

More Involvement for Patients in Developing New Medicines

The Innovative Medicines Initiative (IMI) says it is creating a ‘pool’ of patient experts to strengthen the role and voice of patients in IMI activities at both strategic and operational levels.  IMI says it has always involved patients in its work, adding, “now the plan is to take patient engagement at IMI to the next level.”…